Blog
RSS FeedPosted by Michael Wonder on 13 May 2020
NICE backs drug for lymphoma from Roche
13 May 2020 - NICE has recommended NHS funding for a cancer drug, giving final guidance on a new option ...
Posted by Michael Wonder on 13 May 2020
NICE final guidance backs Pfizer's Lorviqua
13 May 2020 - NICE has published guidance recommending the use of Pfizer's Lorviqua (lorlatinib) for a certain form of ...
Posted by Michael Wonder on 12 May 2020
A comparison of the EQ-5D-3L and EQ-5D-5L
12 May 2020 - Previous studies have found the EQ-5D-5L to have superior measurement properties but no study has compared ...
Posted by Michael Wonder on 11 May 2020
Exploration of the visibility of patient input in final recommendation documentation for three health technology assessment bodies
7 May 2020 - Health technology assessment recommendations informed by patient concerns are seen to ensure democracy and legitimacy. ...
Posted by Michael Wonder on 07 May 2020
NICE draft guidance recommends new treatment option for people with early breast cancer
7 May 2020 - NICE has today published draft guidance which recommends trastuzumab emtansine (also called Kadcyla and made by Roche) ...
Posted by Michael Wonder on 30 Apr 2020
NICE joins international collaboratives to respond to the COVID-19 pandemic
30 April 2020 - NICE is supporting a growing number of international collaborations to share knowledge and identify treatments in response ...
Posted by Michael Wonder on 28 Apr 2020
NICE U-turn backs Stelara for ulcerative colitis
28 April 2020 - NICE has now issued a positive Final Appraisal Document recommending Janssen's Stelara (ustekinumab) as an option ...
Posted by Michael Wonder on 23 Apr 2020
NICE publishes two new COVID-19 guidelines
23 April 2020 - NICE has published 2 new rapid COVID-19 guidelines on the care of patients with suspected and confirmed ...
Posted by Michael Wonder on 22 Apr 2020
UK underinvested in health care, says pharma boss
22 April 2020 - The UK has underinvested in health care "over many years" which has hampered its ability to ...
Posted by Michael Wonder on 21 Apr 2020
Andexanet alfa for reversing anticoagulation
21 April 2020 - The Department of Health and Social Care has asked NICE to produce guidance on using andexanet alfa ...
Posted by Michael Wonder on 21 Apr 2020
NICE recommends Vitrakvi (larotrectinib) for use on Cancer Drugs Fund
21 April 2020 - Larotrectinib has been given a positive opinion by NICE, following the submission of a revised price after ...
Posted by Michael Wonder on 16 Apr 2020
Aid groups ask UK gov to stop pharma 'profiteering' from COVID-19
16 April 2020 - As of this morning – Thursday April 16 – the current recorded case count for COVID-19 ...
Posted by Michael Wonder on 09 Apr 2020
NICE publishes new COVID-19 guidelines on cystic fibrosis, chronic obstructive pulmonary disease and dermatological conditions treated with drugs affecting the immune response
9 April 2020 - NICE has today published 3 new rapid guidelines on the care of patients with suspected and confirmed ...
Posted by Michael Wonder on 04 Apr 2020
NICE publishes new COVID-19 guidelines on severe asthma, pneumonia, rheumatological disorders and symptom management
4 April 2020 - They cover the management of patients with severe asthma, pneumonia, rheumatological autoimmune, inflammatory and metabolic bone disorders ...
Posted by Michael Wonder on 02 Apr 2020
A NICE transformation?
1 April 2020 - Will the NICE Review of Methods and Processes pave the way to HTA reform? ...